CureVac's Partnership

CureVac raised a round of funding on October 17, 2017. Investors include Eli Lilly & Co..

CureVac, a German clinical stage biopharmaceutical company founded in 2000, is pioneering the field of mRNA-based technology platforms for medical purposes, in which unmodified mRNA is specifically op…

Articles about CureVac's Partnership: